A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation

Eur Respir J. 2015 Feb;45(2):541-4. doi: 10.1183/09031936.00137814. Epub 2014 Oct 30.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / drug therapy*
  • Double-Blind Method
  • Dry Powder Inhalers
  • Humans
  • Lung Diseases / complications
  • Lung Diseases / drug therapy*
  • Mannitol / administration & dosage*
  • Oxygen Consumption
  • Pilot Projects
  • Powders / administration & dosage*
  • Respiratory Function Tests
  • Sample Size
  • Spirometry
  • Treatment Outcome

Substances

  • Powders
  • Mannitol

Associated data

  • ANZCTR/ACTRN12612001167853